EFFECTIVENESS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS: A COMBINED ANALYSIS OF REAL-WORLD EVIDENCE

被引:0
作者
Cummings, Fraser
Buisson, Anthony
Smith, Philip J.
Rahmany, Sohail
Subramanian, Sreedhar
Kwon, Buki
Park, Soyeon
Lee, Young Nam
Fumery, Mathurin
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo1854
引用
收藏
页码:S1144 / S1144
页数:1
相关论文
共 50 条
[21]   Calibrating real-world evidence studies against randomized trials: Treatment effectiveness of infliximab in inflammatory bowel disease [J].
Kirchgesner, Julien ;
Desai, Rishi J. ;
Schneeweiss, Maria C. ;
Beaugerie, Laurent ;
Kim, Seoyoung C. ;
Schneeweiss, Sebastian .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 :41-42
[22]   Multiple Biosimilar Infliximab Switching is Not Associated with Adverse Outcomes in Inflammatory Bowel Disease: A Real-World Effectiveness Analysis in a National US Cohort [J].
Hou, J. K. ;
Pham, C. ;
Xu, A. ;
Sansgiry, S. ;
Modi, V. ;
Waljee, A. .
JOURNAL OF CROHNS & COLITIS, 2024, 18 :I1327-I1327
[23]   Persistence of subcutaneous infliximab after two years of the switch from intravenous infliximab to subcutaneous infliximab in Inflammatory Bowel Disease patients [J].
Huguet, J. M. ;
Iborra, M. ;
Marti, L. ;
Bosca-Watts, M. M. ;
Ramirez, J. J. ;
Ruiz, L. ;
Sanchis, L. ;
Garrido, A. ;
Alemany, G. ;
Suria, C. ;
Paredes, J. M. .
JOURNAL OF CROHNS & COLITIS, 2024, 18 :I1242-I1242
[24]   Environmental impact and costs of a switching program of intravenous to subcutaneous infliximab in Inflammatory Bowel Disease [J].
Oliveira, R. ;
Roseira, J. ;
Araujo, N. ;
Cavaco, C. ;
Andre, J. ;
Sousa, M. ;
Tavares de Sousa, H. ;
Cunha, M. .
JOURNAL OF CROHNS & COLITIS, 2025, 19 :i1681-i1681
[25]   EFFICACY, SAFETY AND PHARMACOKINETIC DATA OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INACTIVE INFLAMMATORY BOWEL DISEASE PATIENTS. REAL-LIFE EVIDENCE FROM ENEIDA REGISTRY [J].
Iborra, Marisa ;
Marin, Alejandro Garrido ;
Oliva, Berta Caballol ;
Huguet, Jose Maria ;
Garcia, Lara Arias ;
Mesonero, Francisco ;
Fernandez-Prada, Samuel J. ;
Watts, Marta M. Bosca ;
Diaz, Angel Ponferrada ;
Calvet, Xavier ;
Gutierrez, Ana ;
Ordas, Ingrid ;
Ruiz-Sanchez, Lucia ;
Sicilia, Beatriz ;
de la Filia, Irene Garcia ;
Domenech, Eugeni ;
Nos, Pilar .
GASTROENTEROLOGY, 2023, 164 (06) :S95-S95
[26]   Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease [J].
Volkers, A. ;
Straatmijer, T. ;
Duijvestein, M. ;
Sales, A. ;
Levran, A. ;
van Schaik, F. ;
Jeroen, M. ;
Gecse, K. ;
Ponsioen, C. ;
Grootjans, J. ;
Hanzel, J. ;
Tack, G. ;
Jansen, J. ;
Hoentjen, F. ;
de Boer, N. ;
van der Marel, S. ;
Dijkstra, G. ;
Oldenburg, B. ;
Lowenberg, M. ;
van der Meulen, A. ;
D'Haens, G. .
JOURNAL OF CROHNS & COLITIS, 2022, 16 :I108-I109
[27]   MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH DISEASE FLARE IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL US COHORT [J].
Hou, Jason ;
Pham, Codey ;
Xu, Anthony ;
Sansgiry, Shubhada ;
Modi, Varsha ;
Waljee, Akbar .
GASTROENTEROLOGY, 2024, 166 (03) :S9-S9
[28]   MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH DISEASE FLARE IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL US COHORT [J].
Hou, Jason ;
Pham, Codey ;
Xu, Anthony ;
Sansgiry, Shubhada ;
Modi, Varsha ;
Waljee, Akbar .
INFLAMMATORY BOWEL DISEASES, 2024, 30 :S7-S7
[29]   Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission [J].
Parisio, Laura ;
Settanni, Carlo Romano ;
Varca, Simone ;
Laterza, Lucrezia ;
Lopetuso, Loris Riccardo ;
Napolitano, Daniele ;
Schiavoni, Elisa ;
Turchini, Laura ;
Fanali, Caterina ;
Alfieri, Norma ;
Pizzoferrato, Marco ;
Papa, Alfredo ;
Pafundi, Pia Clara ;
Armuzzi, Alessandro ;
Gasbarrini, Antonio ;
Pugliese, Daniela ;
Scaldaferri, Franco .
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2023, 32 (04) :452-459
[30]   PRECISION DOSING TEST IN OPTIMIZING INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EVIDENCE STUDY [J].
Abraham, Bincy P. ;
Fatima, Ayesha ;
Battat, Robert J. ;
Carroll, Kristin ;
Torres, Esther A. ;
Rabizadeh, Shervin ;
Ziring, David ;
Gohndrone, Judith ;
Lum, Donald ;
Arai, Ronen ;
Ali, Tauseef ;
Allen, Mark J. ;
Condino, Adria A. ;
Stein, Daniel J. ;
Pandey, Akash ;
Barrett, Terrence ;
Ritter, Timothy E. ;
Bray, Harry ;
Hanauer, Stephen B. ;
Dervieux, Thierry ;
Colombel, Jean Frederic .
GASTROENTEROLOGY, 2023, 164 (06) :S1111-S1111